tbuckley/cabot-search huggingface dataset:
The Problem of Pulmonary Scar Tumors
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Economics
Authors: C. J. Schramm
Journal: JAMA (1990)

Spurred by customer demands for greater control of medical care expenses, commercial insurers began during the 1980s to transform their business—from claims payer to manager of health care delivery systems. At the turn of the decade, employers did not generally regard rising health insurance costs as a major problem.<sup>1</sup>However, as the energy-driven inflation of the 1970s cooled in the early 1980s, annual increases in health benefit plans accelerated to more than 20% (unpublished data from the Employer Cost Index of the Bureau of Labor Statistics). Businesses began to support insurance companies' efforts to take a more active role in improving the value employers received for their health care dollars. Insurers responded by undertaking the arduous process of examining the delivery systems their claims were supporting and constructing techniques and programs to manage the care provided. As the programs have developed, different insurers have defined "managed care" differently. Some
Community survey of factors associated with consultation for low back pain
Journal: BMJ (1999)

Objective To investigate the psychosocial factors associated with consultation for low back pain.Design Two phase cross sectional postal survey.Setting Bradford Metropolitan Health District.Subjects 1813 adults responding to the phase 1 questionnaire.540 of the 782 with an episode of low back pain in the past 12 months completed the second questionnaire. Main outcome measures Six psychosocial constructs.Results 406 (52%) of the respondents reporting back pain in the past 12 months had not consulted a health professional.Logistic regression showed that consultation was associated with externalised beliefs regarding pain management (odds ratio 3.6; 95% confidence interval 2.1 to 6.0).Duration of pain affected the factors associated with consultation.Consultation for episodes lasting less than two weeks (n = 290) was associated with greater than median pain (3.0; 1.7 to 5.5), consultation for episodes over two weeks (n = 243) was associated with increased disability (3.7; 1.5 to 9.0), and consultation for episodes over three months (n = 143) with increased depression (3.9; 1.3 to 11.8).Conclusions The results support a role for psychosocial factors in consultation for low back pain and suggest that the reasons for consultation vary with duration of pain.Duration of the episode may be a useful guide to management of non-specific low back pain.
Charaka Samhita.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Superior Mesenteric Venous Occlusion: Study Using Low Molecular-Weight Dextran to Prevent Infarction
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
DECREASE OF DEATH FROM CONSUMPTION.
Journal: JAMA (1898)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PSYCHOLOGICAL FACTORS IN WOMEN WITH PEPTIC ULCERS
Authors: EDWARD KEZUR, FREDERIC T. KAPP, MILTON ROSENBAUM
Journal: American Journal of Psychiatry (1951)

Twenty-five women with peptic ulcers were studied from the psychosomatic point of view. All exhibited profound and overt personality disorders. The majority had been rejected by the mother and turned to the father for support. Ulcer symptoms were precipitated when the supporting figure failed them. Oral aggressive feelings played an important role and were often equated with denial of femininity. This group of women with peptic ulcers had a much higher incidence of overt personality disturbances than the majority of a comparative group of men peptic ulcer patients previously studied, although frustration of dependent wishes was equally important in both groups. The shift in the sex ratio of peptic ulcer during the past 50 years suggests that cultural factors may play a role in the development of this disease.
Deputy Surgeon-General (Retired) Thomas Knox Birnie
Journal: BMJ (1890)

becoming a Member of the Bo al College of Sur- geons of England in 1831, and commen ctice n the same year.in conjunction with other medica men there he worked gratuitously during the cholera epidemic in that and the followg year, being presented with the freedom of the City of Plymouth and a handsome silver-gilt snuffbox as a memento of his services.At the end of 1832 Mr. Stiles began to practise suC- cessfully at Sutton Bener, Wilts, leaving there for Chippenham in 1846, where he contmued to practise until three year ago, when failing health compelled him to retire.He married in 1834
OPERATION FOR CHRONIC NEPHRITIS.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
World Arthritis Day 2018 and National Mental Illness Awareness Week
Journal: MMWR Morbidity and Mortality Weekly Report (2018)

Arthritis Day encourages organizations and individuals to work toward increasing awareness about arthritis and other rheumatic conditions worldwide.National Mental Illness Awareness Week seeks to educate the public, combat stigma, and provide support to those affected by mental illness.A report in this issue found that adults with arthritis had higher prevalences of symptoms of anxiety (22.5%) and depression (12.1%) compared with adults without arthritis (1).Community-delivered self-management educational programs, such as the Chronic Disease Self-Management Program, § can increase self-efficacy (confidence) and physical activity (e.g., walking), improve self-rated health, and reduce depression, fatigue, and pain (2).CDC works with national and state partners to disseminate these educational programs in communities.
Adult hypertrophic pyloric stenosis managed by double pyloroplasty
Authors: G. J. Brahos
Journal: JAMA (1980)

HYPERTROPHIC pyloric stenosis is a relatively rare cause of gastricoutlet obstruction in adults. Although various classifications and possible causes have been described,<sup>1</sup>when the secondary forms are eliminated, there remains an entity that appears to be distinct and truly congenital in origin.<sup>1-4</sup>As in infants with the congenital form, the pylorus in the adult disorder is characterized by thickening and hypertrophy of the pyloric muscle, but with absence of fibrosis, which would imply inflammation.<sup>1</sup>The two conditions differ mainly in that obstructive symptoms in the adult form become manifest much later in life. Infantile hypertrophic pyloric stenosis is well known, and its surgical management seems clearly defined. However, probably because experience is limited, the most appropriate surgical approach for the adult form is as yet undetermined. We describe a case that is, to our knowledge, the first to be managed by the double pyloroplasty technique, and it
PYODERMA UANGRENOSA.*
Authors: ROBERT GIBSON
Journal: British Journal of Dermatology (1937)

Journal Article PYODERMA UANGRENOSA. Get access ROBERT GIBSON, M.D. ROBERT GIBSON, M.D. Hon. Physician, Hospital for Diseases of the Skin, Manchester Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology and Syphilis, Volume 49, Issue 12, 1 December 1937, Pages 560–563, https://doi.org/10.1111/j.1365-2133.1937.tb10387.x Published: 01 December 1937
The role of iatrogenic disease in admissions to intensive care
Authors: P. Trunet
Journal: JAMA (1980)

We prospectively studied all patients admitted to a multidisciplinary intensive care unit to determine how many of their diseases were iatrogenic and, of these, what number were potentially avoidable. Of 325 patients admitted in the course of one year, 41 (12.6%) were hospitalized because of iatrogenic disease. Many of these patients had concomitant serious illnesses. Nevertheless, 19 patients (46.3%) were admitted with iatrogenic disease resulting from therapeutic or technical errors that were potentially avoidable. latrogenic disease was fatal in eight cases, life-threatening in 13, moderate in 20. (<i>JAMA</i>1980;244:2617-2620)
Myc stimulates B lymphocyte differentiation and amplifies calcium signaling
Authors: Tania Habib, Heon Park, Mark Tsang, Ignacio Moreno de Alborán, Andrea Nicks, Leslie Wilson, Paul S. Knoepfler, Sarah Andrews, David J. Rawlings, Robert N. Eisenman, Brian M. Iritani
Journal: The Journal of Experimental Medicine (2007)
Cerebral Responsiveness in Psychiatric Patients
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs
Authors: Ulrich Matt, Omar Sharif, Rui Martins, Tanja Furtner, Lorene Langeberg, Riem Gawish, Immanuel Elbau, Ana Zivkovic, Karin Lakovits, Olga Oskolkova, Bianca Doninger, Andreas Vychytil, Thomas Perkmann, Gernot Schabbauer, Christoph J. Binder, Valery N. Bochkov, John D. Scott, Sylvia Knapp
Journal: Journal of Clinical Investigation (2013)

In Figure 7, C and D, the term AG-1478
Common Diseases of the Skin with Notes on Diagnosis and Treatment.
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CEREBROSPINAL RHINORRHEA FOLLOWING INTRANASAL SURGERY
Journal: JAMA (1929)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Crucial Test of Therapeutic Evidence
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
Authors: Alissa A. Thomas, Kathryn Beal, Katharine Anne McNeill, Thomas Joseph Kaley, Lisa Marie DeAngelis, Ingo K. Mellinghoff, Eli L. Diamond, Timothy An-thy Chan, Robert J. Young, Julio Arevalo Perez, Yoshiya Yamada, Barry Douglas Anderson, Michael Lamson, Brandon Burch, Rashida A. Karmali, Antonio Marcilio Padula Omuro
Journal: Journal of Clinical Oncology (2015)

2062 Background: CTO is an oral inhibitor of non-voltage-dependent calcium signaling that results in simultaneous modulation of several receptor-mediated signaling pathways. A single-agent phase I trial determined the maximum tolerated dose (MTD) at 427 mg/m2, with a safe toxicity profile. A phase IB in combination with TMZ for recurrent malignant glioma found therapeutic brain tissue concentrations and early evidence of activity, with radiographic responses and median survival of 15 months, prompting this newly diagnosed disease study. Methods: Following a 3+3 design, pts were enrolled to receive escalating doses of daily CTO (219-481mg/m2) added to the standard GBM RT regimen (60 Gy concurrent with TMZ 75 mg/m2 daily, followed by adjuvant TMZ 150-200 mg/m2 X5/28 days). Results: All enrolled pts (N = 15) had GBM (methylated MGMT: 33%; unmethylated: 67%). Next generation sequencing (N = 9) showed mutations involving TERT (56%), EGFR (33%), IDH-1 (22%) and TP53 (44%), among others. ChemoRT was well tolerated at CTO doses of 219-481 mg/m2, with no dose-limiting toxicities (DLT) observed during the DLT period; adverse events included fatigue, nausea, constipation and headache. DLTs were however observed beyond the DLT observation period, and after RT: Gr 3 febrile neutropenia (N = 2), gr 4 neutropenia (N = 1), gr 4 platelets (N = 1) and gr 3 ALT/AST (N = 1). This prompted a halt in dose escalation at 481 mg/m2 (declared the maximum administered dose, MAD) and expansion of a lower dose level (370 mg/m2). Efficacy evaluation is ongoing, with one confirmed partial response and stable diseases for 7+ cycles. PK data confirmed therapeutic levels starting at 219 mg/m2. Tissue and DCE-perfusion MRI correlates are ongoing. Conclusions: CTO in combination with RT and TMZ is safe and well tolerated. The MAD dose was 481 mg/m2 and recommended phase II dose is 370 mg/m2, although further evaluation of this dose level and longer follow up may be warranted. Further phase IB studies of CTO should consider designs such as continuous reassessment method, which better address late toxicities in comparison to a 3+3 design. Given encouraging signals of activity, a randomized study is warranted. Clinical trial information: NCT01107522.
WHEN IS A PATIENT DEAD?
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal